Data:
{
"symbol": "HALO",
"price": 113.216,
"marketCap": 13428889408,
"beta": 0.882,
"lastDividend": 0,
"range": "61.23-116.85",
"change": 0.776,
"changePercentage": 0.69015,
"volume": 29904.05452,
"averageVolume": 2024928,
"companyName": "Halozyme Therapeutics, Inc.",
"currency": "USD",
"cik": "0001159036",
"isin": "US40637H1095",
"cusip": "40637H109",
"exchangeFullName": "NASDAQ Global Select",
"exchange": "NASDAQ",
"industry": "Biotechnology",
"website": "https://www.halozyme.com",
"description": "Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20). This innovative technology significantly enhances the subcutaneous (under-the-skin) administration of a diverse range of injectable medicines. This includes complex biologics such as monoclonal antibodies, various other therapeutic molecules, smaller drug compounds, and even fluids. The company's leading product, Hylenex recombinant, is an rHuPH20 formulation specifically designed to facilitate subcutaneous fluid delivery for hydration. It also plays a crucial role in improving the dispersion and absorption of other injected drugs during subcutaneous urography, and aids in the resorption of radiopaque agents. Halozyme also offers several key therapeutics leveraging its platform, including Perjeta, RITUXAN HYCELA, and MabThera SC, which are used to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL). RITUXAN SC is another offering for CLL patients, while HYQVIA addresses various immunodeficiency disorders. Their development pipeline boasts numerous investigational drugs, such as Tecentriq for non-small cell lung cancer, OCREVUS for multiple sclerosis, and DARZALEX, which targets amyloidosis, smoldering myeloma, and multiple myeloma. Other pipeline candidates include nivolumab for solid tumors, ARGX-113 (a human neonatal Fc receptor), ARGX-117 for autoimmune diseases, and BMS-986179, an anti-CD-73 antibody. Halozyme maintains extensive collaborations with prominent pharmaceutical companies like F. Hoffmann-La Roche, Pfizer Inc., Janssen Biotech, Inc., AbbVie, Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Alexion Pharma Holding, ARGENX BVBA, and Horizon Therapeutics plc. They also partner with research institutions such as the National Institute of Allergy and Infectious Diseases, the Centre for the AIDS Programme of Research in South Africa, and ViiV Healthcare Limited, particularly focusing on both small and large molecule targets for the treatment and prevention of HIV. The company was established in 1998.",
"ceo": "Helen I. Torley",
"sector": "Healthcare",
"country": "US",
"fullTimeEmployees": "423",
"phone": "858 794 8889",
"address": "12390 El Camino Real",
"city": "San Diego",
"state": "CA",
"zip": "92130",
"image": "https://images.financialmodelingprep.com/symbol/HALO.png",
"ipoDate": "2004-03-16",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": false,
"isFund": false
}
Data:
{
"symbol": "HALO",
"name": "Halozyme Therapeutics, Inc.",
"price": 112.89,
"changePercentage": -0.88674,
"change": -1.01,
"volume": 2236704,
"dayLow": 112.1,
"dayHigh": 113.9399,
"yearHigh": 116.85,
"yearLow": 61.23,
"marketCap": 13390221570,
"priceAvg50": 100.4452,
"priceAvg200": 77.3851,
"exchange": "NASDAQ",
"open": 113.34,
"previousClose": 113.9,
"timestamp": 1790625601,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-18",
"v": 104.3772,
"c": 104.89
},
{
"t": "2026-08-19",
"v": 107.0574,
"c": 107.62
},
{
"t": "2026-08-20",
"v": 106.3732,
"c": 106.12
},
{
"t": "2026-08-21",
"v": 107.9621,
"c": 108.17
},
{
"t": "2026-08-24",
"v": 108.2531,
"c": 108.64
},
{
"t": "2026-08-25",
"v": 109.0797,
"c": 109.32
},
{
"t": "2026-08-26",
"v": 107.8038,
"c": 107.06
},
{
"t": "2026-08-27",
"v": 106.7971,
"c": 106.92
},
{
"t": "2026-08-28",
"v": 105.301,
"c": 105.35
},
{
"t": "2026-08-31",
"v": 106.1419,
"c": 106.49
},
{
"t": "2026-09-01",
"v": 107.4537,
"c": 107.72
},
{
"t": "2026-09-02",
"v": 108.9462,
"c": 109.66
},
{
"t": "2026-09-03",
"v": 110.0925,
"c": 110.76
},
{
"t": "2026-09-04",
"v": 110.0757,
"c": 110.19
},
{
"t": "2026-09-08",
"v": 108.2015,
"c": 108.31
},
{
"t": "2026-09-09",
"v": 107.3688,
"c": 107.39
},
{
"t": "2026-09-10",
"v": 107.0852,
"c": 107
},
{
"t": "2026-09-11",
"v": 107.2631,
"c": 107.2
},
{
"t": "2026-09-14",
"v": 107.8728,
"c": 107.94
},
{
"t": "2026-09-15",
"v": 106.5365,
"c": 106.25
},
{
"t": "2026-09-16",
"v": 107.9289,
"c": 108.44
},
{
"t": "2026-09-17",
"v": 109.2681,
"c": 109.68
},
{
"t": "2026-09-18",
"v": 111.349,
"c": 112.45
},
{
"t": "2026-09-21",
"v": 111.9406,
"c": 111.45
},
{
"t": "2026-09-22",
"v": 114.1876,
"c": 115.13
},
{
"t": "2026-09-23",
"v": 113.4585,
"c": 112.44
},
{
"t": "2026-09-24",
"v": 114.8421,
"c": 115.22
},
{
"t": "2026-09-25",
"v": 114.1423,
"c": 113.9
},
{
"t": "2026-09-28",
"v": 113.035,
"c": 112.89
}
],
"vwap_summary": {
"days": 29,
"days_above": 20,
"days_below": 9,
"pct_days_above": 69,
"position": "below",
"gap_pct": -0.13,
"streak_days": 2
}
}
Data:
{
"volume": 2236704,
"avgVolume": 2024928,
"short_ratio": [
{
"symbol": "HALO",
"file_date": "2026-09-28",
"date": "20260928",
"short_volume": 579843,
"short_exempt_volume": 43300,
"total_volume": 830219,
"short_volume_ratio": 0.6984,
"signal": "Bearish"
}
],
"volume_profile": {
"poc": 110.74,
"vah": 113.28,
"val": 106.97,
"profile": [
{
"price": 105.84,
"volume": 26480
},
{
"price": 106.01,
"volume": 74620
},
{
"price": 106.19,
"volume": 10217
},
{
"price": 106.36,
"volume": 188152
},
{
"price": 106.54,
"volume": 446727
},
{
"price": 106.71,
"volume": 329176
},
{
"price": 106.89,
"volume": 479718
},
{
"price": 107.06,
"volume": 594662
},
{
"price": 107.24,
"volume": 900292
},
{
"price": 107.41,
"volume": 825704
},
{
"price": 107.59,
"volume": 756229
},
{
"price": 107.76,
"volume": 744951
},
{
"price": 107.94,
"volume": 514986
},
{
"price": 108.11,
"volume": 364565
},
{
"price": 108.29,
"volume": 478353
},
{
"price": 108.46,
"volume": 385854
},
{
"price": 108.64,
"volume": 420927
},
{
"price": 108.81,
"volume": 462115
},
{
"price": 108.99,
"volume": 444977
},
{
"price": 109.16,
"volume": 596743
},
{
"price": 109.34,
"volume": 398530
},
{
"price": 109.51,
"volume": 541439
},
{
"price": 109.69,
"volume": 473132
},
{
"price": 109.86,
"volume": 361891
},
{
"price": 110.04,
"volume": 346285
},
{
"price": 110.21,
"volume": 775458
},
{
"price": 110.39,
"volume": 1049192
},
{
"price": 110.56,
"volume": 487917
},
{
"price": 110.74,
"volume": 1714838
},
{
"price": 110.91,
"volume": 668011
},
{
"price": 111.09,
"volume": 906355
},
{
"price": 111.26,
"volume": 991353
},
{
"price": 111.44,
"volume": 577399
},
{
"price": 111.61,
"volume": 1063756
},
{
"price": 111.79,
"volume": 1170937
},
{
"price": 111.96,
"volume": 776502
},
{
"price": 112.14,
"volume": 442523
},
{
"price": 112.31,
"volume": 755936
},
{
"price": 112.49,
"volume": 853365
},
{
"price": 112.66,
"volume": 448938
},
{
"price": 112.84,
"volume": 764200
},
{
"price": 113.01,
"volume": 387456
},
{
"price": 113.19,
"volume": 570322
},
{
"price": 113.36,
"volume": 278118
},
{
"price": 113.54,
"volume": 515657
},
{
"price": 113.71,
"volume": 870517
},
{
"price": 113.89,
"volume": 558282
},
{
"price": 114.06,
"volume": 1345668
},
{
"price": 114.24,
"volume": 791400
},
{
"price": 114.41,
"volume": 610896
},
{
"price": 114.59,
"volume": 1092654
},
{
"price": 114.76,
"volume": 236961
},
{
"price": 114.94,
"volume": 419822
},
{
"price": 115.11,
"volume": 496239
},
{
"price": 115.29,
"volume": 353032
},
{
"price": 115.46,
"volume": 46608
},
{
"price": 115.64,
"volume": 295345
},
{
"price": 115.81,
"volume": 61837
},
{
"price": 115.99,
"volume": 153252
},
{
"price": 116.16,
"volume": 38443
}
],
"sessions": 20
}
}
Data:
{
"symbol": "HALO",
"marketCap": 13390221570,
"enterpriseValueTTM": 15373737570,
"evToSalesTTM": 9.240479913303657,
"evToOperatingCashFlowTTM": 18.780639473732432,
"evToFreeCashFlowTTM": 19.068816569588602,
"evToEBITDATTM": 21.531000983154723,
"netDebtToEBITDATTM": 2.7779246752228204,
"currentRatioTTM": 2.7088221717052945,
"incomeQualityTTM": 1.9792140156094353,
"grahamNumberTTM": 9.85527381229714,
"grahamNetNetTTM": -15.284071917048962,
"taxBurdenTTM": 0.709016042157377,
"interestBurdenTTM": 0.9663657703833901,
"workingCapitalTTM": 588585000,
"investedCapitalTTM": 2177031000,
"returnOnAssetsTTM": 0.1604697432459277,
"operatingReturnOnAssetsTTM": 0.35979624873836386,
"returnOnTangibleAssetsTTM": 0.38537391228186235,
"returnOnEquityTTM": 1.8062774863850954,
"returnOnInvestedCapitalTTM": 0.2742317247175858,
"returnOnCapitalEmployedTTM": 0.42297407621870253,
"earningsYieldTTM": 0.03124058217822996,
"freeCashFlowYieldTTM": 0.060209907340614675,
"capexToOperatingCashFlowTTM": 0.015112479309060036,
"capexToDepreciationTTM": 0.1060450204872362,
"capexToRevenueTTM": 0.007435665952211226,
"salesGeneralAndAdministrativeToRevenueTTM": 0.13481389497625226,
"researchAndDevelopementToRevenueTTM": 0.06153132284049532,
"stockBasedCompensationToRevenueTTM": 0.03790620879008594,
"intangiblesToTotalAssetsTTM": 0.58359988018971,
"averageReceivablesTTM": 456908000,
"averagePayablesTTM": 18853000,
"averageInventoryTTM": 146301000,
"daysOfSalesOutstandingTTM": 100.00183622661741,
"daysOfPayablesOutstandingTTM": 23.73342954959223,
"daysOfInventoryOutstandingTTM": 137.863599681605,
"operatingCycleTTM": 237.86543590822242,
"cashConversionCycleTTM": 214.13200635863018,
"freeCashFlowToEquityTTM": 1041593000,
"freeCashFlowToFirmTTM": 820619152.7039212,
"tangibleAssetValueTTM": -1360632000,
"netCurrentAssetValueTTM": -1500841000,
"grossProfitMarginTTM": 0.7817739331553406,
"ebitMarginTTM": 0.3628221510838846,
"ebitdaMarginTTM": 0.4291709391743171,
"operatingProfitMarginTTM": 0.5676903454750688,
"pretaxProfitMarginTTM": 0.3506189075443369,
"continuousOperationsProfitMarginTTM": 0.24859443013262905,
"netProfitMarginTTM": 0.24859443013262905,
"bottomLineProfitMarginTTM": 0.24859443013262905,
"receivablesTurnoverTTM": 3.649932978959123,
"payablesTurnoverTTM": 15.379151135208405,
"inventoryTurnoverTTM": 2.647544390564043,
"fixedAssetTurnoverTTM": 19.742711015651885,
"assetTurnoverTTM": 0.6455082004866906,
"quickRatioTTM": 2.310682007554313,
"solvencyRatioTTM": 0.21528844040240522,
"cashRatioTTM": 0.4736339380848278,
"priceToEarningsRatioTTM": 32.07102272727273,
"priceToEarningsGrowthRatioTTM": -1.4966477272727263,
"forwardPriceToEarningsGrowthRatioTTM": 1.1298963223720255,
"priceToEarningsDilutedRatioTTM": 33.698507462686564,
"priceToEarningsDilutedGrowthRatioTTM": -1.4437497805092177,
"priceToBookRatioTTM": 92.23063374737885,
"priceToSalesRatioTTM": 8.04827537148277,
"priceToFreeCashFlowRatioTTM": 16.60856234743694,
"priceToOperatingCashFlowRatioTTM": 16.172908287981237,
"debtToAssetsRatioTTM": 0.8328731811183949,
"debtToEquityRatioTTM": 14.954780100736365,
"debtToCapitalRatioTTM": 0.9373228591252194,
"longTermDebtToCapitalRatioTTM": 0.9310296281952906,
"financialLeverageRatioTTM": 17.9556509199334,
"workingCapitalTurnoverRatioTTM": 2.7087644119109973,
"operatingCashFlowRatioTTM": 2.3766036947035616,
"operatingCashFlowSalesRatioTTM": 0.49202158032093996,
"freeCashFlowOperatingCashFlowRatioTTM": 0.98488752069094,
"debtServiceCoverageRatioTTM": 2.373964662214914,
"interestCoverageRatioTTM": 46.51962764123529,
"shortTermOperatingCashFlowCoverageRatioTTM": 3.91728477771929,
"operatingCashFlowCoverageRatioTTM": 0.38133532464943115,
"capitalExpenditureCoverageRatioTTM": 66.1704793468596,
"dividendPaidAndCapexCoverageRatioTTM": 66.1704793468596,
"dividendPayoutRatioTTM": 0,
"dividendYieldTTM": 0,
"revenuePerShareTTM": 14.1867592134659,
"netIncomePerShareTTM": 3.5267493221003803,
"interestDebtPerShareTTM": 18.477727373501374,
"cashPerShareTTM": 1.9697716458891144,
"bookValuePerShareTTM": 1.2239967938332452,
"tangibleBookValuePerShareTTM": -11.602162457151628,
"shareholdersEquityPerShareTTM": 1.2239967938332452,
"operatingCashFlowPerShareTTM": 6.980191687842147,
"capexPerShareTTM": 0.10548800245578731,
"freeCashFlowPerShareTTM": 6.87470368538636,
"netIncomePerEBTTTM": 0.709016042157377,
"ebtPerEbitTTM": 0.6176235166566436,
"priceToFairValueTTM": 92.23063374737885,
"debtToMarketCapTTM": 0.16031504697498444,
"effectiveTaxRateTTM": 0.290983957842623,
"enterpriseValueMultipleTTM": 21.531000983154723,
"dividendPerShareTTM": 0,
"revenue_history": [
{
"date": "2025",
"revenue": 1396611000
}
],
"dcf": {
"symbol": "HALO",
"date": "2026-09-29",
"dcf": 87.3926623337717,
"Stock Price": 112.89
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "HALO",
"reportedCurrency": "USD",
"cik": "0001159036",
"filingDate": "2026-02-17",
"acceptedDate": "2026-02-17 16:08:23",
"fiscalYear": "2025",
"period": "FY",
"revenue": 1396611000,
"costOfRevenue": 305436000,
"grossProfit": 1091175000,
"researchAndDevelopmentExpenses": 81490000,
"generalAndAdministrativeExpenses": 0,
"sellingAndMarketingExpenses": 0,
"sellingGeneralAndAdministrativeExpenses": 193392000,
"otherExpenses": 0,
"operatingExpenses": 274882000,
"costAndExpenses": 580318000,
"netInterestIncome": -18126000,
"interestIncome": 0,
"interestExpense": 18126000,
"depreciationAndAmortization": 88051000,
"ebitda": 573052000,
"ebit": 485001000,
"nonOperatingIncomeExcludingInterest": 331292000,
"operatingIncome": 816293000,
"totalOtherIncomeExpensesNet": -349418000,
"incomeBeforeTax": 466875000,
"incomeTaxExpense": 149986000,
"netIncomeFromContinuingOperations": 316889000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 316889000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 316889000,
"eps": 2.64,
"epsDiluted": 2.56,
"weightedAverageShsOut": 119840000,
"weightedAverageShsOutDil": 123904000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "HALO",
"reportedCurrency": "USD",
"cik": "0001159036",
"filingDate": "2026-02-17",
"acceptedDate": "2026-02-17 16:08:23",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 133820000,
"shortTermInvestments": 9000000,
"cashAndShortTermInvestments": 142820000,
"netReceivables": 441273000,
"accountsReceivables": 441273000,
"otherReceivables": 0,
"inventory": 176475000,
"prepaids": 0,
"otherCurrentAssets": 64639000,
"totalCurrentAssets": 825207000,
"propertyPlantEquipmentNet": 82137000,
"goodwill": 580360000,
"intangibleAssets": 981467000,
"goodwillAndIntangibleAssets": 1561827000,
"longTermInvestments": 0,
"taxAssets": 0,
"otherNonCurrentAssets": 56152000,
"totalNonCurrentAssets": 1700116000,
"otherAssets": 0,
"totalAssets": 2525323000,
"totalPayables": 20899000,
"accountPayables": 20899000,
"otherPayables": 0,
"accruedExpenses": 0,
"shortTermDebt": 0,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 156193000,
"totalCurrentLiabilities": 177092000,
"longTermDebt": 2142630000,
"capitalLeaseObligationsNonCurrent": 0,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 42924000,
"otherNonCurrentLiabilities": 113863000,
"totalNonCurrentLiabilities": 2299417000,
"otherLiabilities": 0,
"capitalLeaseObligations": 0,
"totalLiabilities": 2476509000,
"treasuryStock": 0,
"preferredStock": 0,
"commonStock": 118000,
"retainedEarnings": 54786000,
"additionalPaidInCapital": 12002000,
"accumulatedOtherComprehensiveIncomeLoss": -18092000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 48814000,
"totalEquity": 48814000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 2525323000,
"totalInvestments": 9000000,
"totalDebt": 2142630000,
"netDebt": 2008810000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "HALO",
"reportedCurrency": "USD",
"cik": "0001159036",
"filingDate": "2026-02-17",
"acceptedDate": "2026-02-17 16:08:23",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 316889000,
"depreciationAndAmortization": 88051000,
"deferredIncomeTax": 634000,
"stockBasedCompensation": 51565000,
"changeInWorkingCapital": -152256000,
"accountsReceivables": -128063000,
"inventory": 2554000,
"accountsPayables": 0,
"otherWorkingCapital": -26747000,
"otherNonCashItems": 346675000,
"netCashProvidedByOperatingActivities": 651558000,
"investmentsInPropertyPlantAndEquipment": -6970000,
"acquisitionsNet": -725965000,
"purchasesOfInvestments": -247355000,
"salesMaturitiesOfInvestments": 722248000,
"otherInvestingActivities": -287771000,
"netCashProvidedByInvestingActivities": -545813000,
"netDebtIssuance": 451132000,
"longTermNetDebtIssuance": 451132000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -320543000,
"netCommonStockIssuance": -320543000,
"commonStockIssuance": 21829000,
"commonStockRepurchased": -342372000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": 0,
"commonDividendsPaid": 0,
"preferredDividendsPaid": 0,
"otherFinancingActivities": -215763000,
"netCashProvidedByFinancingActivities": -85174000,
"effectOfForexChangesOnCash": 0,
"netChangeInCash": 20571000,
"cashAtEndOfPeriod": 136421000,
"cashAtBeginningOfPeriod": 115850000,
"operatingCashFlow": 651558000,
"capitalExpenditure": -6970000,
"freeCashFlow": 644588000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 112.89,
"rsi": 61.38348571330684,
"sma20": 110.02550000000008,
"sma50": 100.4452,
"sma200": 77.38510000000001,
"adx": 36.6795530648134,
"atr": 2.96,
"atr_pct": 2.62,
"atr_expansion_pct": 20.3,
"di_plus": 22.6,
"di_minus": 7.7,
"high_52w": 115.22,
"low_52w": 61.63,
"structure": {
"ema8": 112.58013318764066,
"ema21": 109.56119156618503,
"ema50": 101.38923124601166,
"ema200": 81.81944786269077,
"ema10": 112.13668053715557,
"ema20": 109.82120714036722,
"ema10_slope_pct": 2.62,
"ema20_slope_pct": 2.44,
"trend_dir": "up",
"checks": {
"price_above_all": true,
"ema_stacked": true,
"ema21_rising": true,
"ema50_rising": true,
"adx_over_30": true,
"higher_highs_lows": true,
"lower_highs_lows": false,
"near_21ema": true
},
"dist_21ema_pct": 3.0,
"_no_bars": false,
"macd": {
"macd": 3.505,
"signal": 3.712,
"histogram": -0.207
},
"bollinger": {
"mid": 110.03,
"upper": 115.62,
"lower": 104.43,
"width_pct": 10.18
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": 4.6,
"ret_3d": 0.4,
"ret_5d": 1.29,
"roc10_accel": 3.44,
"checks": {
"roc_over_5": false,
"rsi_in_band": true,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": true
},
"volume": {
"rvol": 0.98,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": true,
"obv_new_high": false,
"surge_day": true,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": 1.94,
"checks": {
"beats_spy_all": true,
"beats_sector_10d": true,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 229254248.44799998
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": false,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.4,
"iv_rank": 43.0
}
}
}
}
Data:
{
"prior_day": {
"high": 113.94,
"low": 112.1,
"close": 112.89,
"date": "2026-09-28"
},
"woodie_pivots": {
"PP": 112.95,
"R1": 113.81,
"S1": 111.97,
"R2": 114.79,
"S2": 111.12
},
"swing": {
"high_20d": 116.84,
"low_20d": 103.47,
"high_60d": 116.84,
"low_60d": 73.89
},
"orb": {
"high": 113.78,
"low": 112.5,
"date": "2026-09-28"
},
"vwap": 113.09,
"volume_profile": {
"poc": 110.74,
"vah": 113.28,
"val": 106.97,
"sessions": 20
},
"intraday": {
"h1_trend": "flat",
"h1_last": 113.55,
"h1_ema9": 113.44,
"h1_ema21": 113.58,
"m15_trend": "down",
"m15_last": 112.64,
"m15_ema9": 113.2,
"m15_ema21": 113.27,
"rvol_intraday": 0.62,
"as_of_et": "2026-09-28 15:55"
},
"premarket": {
"date": "2026-09-29",
"high": 113.12,
"low": 112.88,
"last": 113.12,
"volume": 898,
"gap_pct": 0.2,
"path": "04:50 112.88 -> 09:10 113.12",
"bars": 2,
"last_bar_et": "09:10"
},
"recent_daily": [
{
"d": "2026-08-24",
"o": 108,
"h": 109.1,
"l": 106.87,
"c": 108.64,
"v": 2091282.398839
},
{
"d": "2026-08-25",
"o": 109.33,
"h": 109.5499,
"l": 107.55,
"c": 109.32,
"v": 1598158.921718
},
{
"d": "2026-08-26",
"o": 109.32,
"h": 109.66,
"l": 107,
"c": 107.06,
"v": 1706117.791791
},
{
"d": "2026-08-27",
"o": 106.865,
"h": 107.55,
"l": 106.05,
"c": 106.92,
"v": 1364730.886618
},
{
"d": "2026-08-28",
"o": 106.45,
"h": 106.805,
"l": 104.7001,
"c": 105.35,
"v": 1681929.348752
},
{
"d": "2026-08-31",
"o": 104.48,
"h": 106.94,
"l": 103.47,
"c": 106.49,
"v": 1280007.082651
},
{
"d": "2026-09-01",
"o": 107.45,
"h": 108.53,
"l": 106.87,
"c": 107.72,
"v": 1058736.504749
},
{
"d": "2026-09-02",
"o": 105.84,
"h": 109.76,
"l": 105.48,
"c": 109.66,
"v": 1619587.893877
},
{
"d": "2026-09-03",
"o": 109.84,
"h": 111.15,
"l": 108.74,
"c": 110.76,
"v": 1889664.913895
},
{
"d": "2026-09-04",
"o": 109.91,
"h": 111.149,
"l": 109,
"c": 110.19,
"v": 1010602.440061
},
{
"d": "2026-09-08",
"o": 109,
"h": 109.961,
"l": 106.07,
"c": 108.31,
"v": 1625633.177889
},
{
"d": "2026-09-09",
"o": 107.67,
"h": 108.79,
"l": 106.62,
"c": 107.39,
"v": 1746311.515856
},
{
"d": "2026-09-10",
"o": 106.93,
"h": 107.95,
"l": 106.36,
"c": 107,
"v": 1464410.088997
},
{
"d": "2026-09-11",
"o": 107.96,
"h": 108.225,
"l": 106.34,
"c": 107.2,
"v": 861581.551456
},
{
"d": "2026-09-14",
"o": 108,
"h": 108.61,
"l": 106.65,
"c": 107.94,
"v": 912515.605027
},
{
"d": "2026-09-15",
"o": 108.14,
"h": 108.14,
"l": 106.14,
"c": 106.25,
"v": 1055588.754031
},
{
"d": "2026-09-16",
"o": 106.66,
"h": 109.63,
"l": 105.5,
"c": 108.44,
"v": 1709963.772174
},
{
"d": "2026-09-17",
"o": 107.08,
"h": 110.8799,
"l": 106.82,
"c": 109.68,
"v": 1983651.025465
},
{
"d": "2026-09-18",
"o": 109.72,
"h": 112.66,
"l": 109.3779,
"c": 112.45,
"v": 10183862.416186
},
{
"d": "2026-09-21",
"o": 112.8,
"h": 113.47,
"l": 111.05,
"c": 111.45,
"v": 2876988.245738
},
{
"d": "2026-09-22",
"o": 111.5,
"h": 115.18,
"l": 110.95,
"c": 115.13,
"v": 4151542.388262
},
{
"d": "2026-09-23",
"o": 116.845,
"h": 116.845,
"l": 112.18,
"c": 112.44,
"v": 2702793.414269
},
{
"d": "2026-09-24",
"o": 112.13,
"h": 116.0899,
"l": 111.0701,
"c": 115.22,
"v": 3172136.046721
},
{
"d": "2026-09-25",
"o": 115.36,
"h": 115.625,
"l": 113.43,
"c": 113.9,
"v": 1958390.221081
},
{
"d": "2026-09-28",
"o": 113.34,
"h": 113.9399,
"l": 112.1,
"c": 112.89,
"v": 2236750.462247
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "up",
"etf_r5d": 1.33,
"etf_rvol": 0.8,
"rs_5d": -0.04,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "HALO",
"date": "2030-12-31",
"revenueLow": 1784763681,
"revenueHigh": 2001126755,
"revenueAvg": 1904266667,
"ebitdaLow": 1362735528,
"ebitdaHigh": 1572350106,
"ebitdaAvg": 1478510687,
"ebitLow": 1321680309,
"ebitHigh": 1531294887,
"ebitAvg": 1437455468,
"netIncomeLow": 1067782377,
"netIncomeHigh": 1239510845,
"netIncomeAvg": 1162632129,
"sgaExpenseLow": 286033078,
"sgaExpenseHigh": 320708254,
"sgaExpenseAvg": 305185085,
"epsAvg": 9.38333,
"epsHigh": 10.0038,
"epsLow": 8.61782,
"numAnalystsRevenue": 2,
"numAnalystsEps": 1
},
{
"symbol": "HALO",
"date": "2029-12-31",
"revenueLow": 2008202797,
"revenueHigh": 2251652916,
"revenueAvg": 2142666667,
"ebitdaLow": 1553497128,
"ebitdaHigh": 1792821144,
"ebitdaAvg": 1685681746,
"ebitLow": 1506419055,
"ebitHigh": 1745743071,
"ebitAvg": 1638603673,
"netIncomeLow": 1219131115,
"netIncomeHigh": 1415199284,
"netIncomeAvg": 1327424451,
"sgaExpenseLow": 321842288,
"sgaExpenseHigh": 360858538,
"sgaExpenseAvg": 343391984,
"epsAvg": 10.71333,
"epsHigh": 11.42174,
"epsLow": 9.83932,
"numAnalystsRevenue": 2,
"numAnalystsEps": 1
},
{
"symbol": "HALO",
"date": "2028-12-31",
"revenueLow": 2086362814,
"revenueHigh": 2358923370,
"revenueAvg": 2230576144,
"ebitdaLow": 1741136434,
"ebitdaHigh": 1917741534,
"ebitdaAvg": 1829438984,
"ebitLow": 1687060728,
"ebitHigh": 1863665828,
"ebitAvg": 1775363278,
"netIncomeLow": 1367123292,
"netIncomeHigh": 1511808473,
"netIncomeAvg": 1439465882.5,
"sgaExpenseLow": 334368512,
"sgaExpenseHigh": 378050113,
"sgaExpenseAvg": 357480694,
"epsAvg": 11.72086,
"epsHigh": 12.20145,
"epsLow": 11.03373,
"numAnalystsRevenue": 5,
"numAnalystsEps": 3
},
{
"symbol": "HALO",
"date": "2027-12-31",
"revenueLow": 1979951870,
"revenueHigh": 2130709626,
"revenueAvg": 2050305490,
"ebitdaLow": 1587609126,
"ebitdaHigh": 1687734046,
"ebitdaAvg": 1637671586,
"ebitLow": 1524982161,
"ebitHigh": 1625107081,
"ebitAvg": 1575044621,
"netIncomeLow": 1234339092,
"netIncomeHigh": 1316367257,
"netIncomeAvg": 1275353174.5,
"sgaExpenseLow": 317314686,
"sgaExpenseHigh": 341475703,
"sgaExpenseAvg": 328589827,
"epsAvg": 10.29833,
"epsHigh": 10.62409,
"epsLow": 9.96206,
"numAnalystsRevenue": 6,
"numAnalystsEps": 4
}
],
"price_target": {
"symbol": "HALO",
"targetHigh": 115,
"targetLow": 90,
"targetConsensus": 103,
"targetMedian": 105
},
"ratings": {
"symbol": "HALO",
"rating": "B+",
"overallScore": 3,
"discountedCashFlowScore": 4,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 5,
"debtToEquityScore": 1,
"priceToEarningsScore": 2,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "HALO",
"date": "2026-09-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-08-07",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-08-07",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-08-07",
"gradingCompany": "Leerink Partners",
"previousGrade": "Market Perform",
"newGrade": "Outperform",
"action": "upgrade"
},
{
"symbol": "HALO",
"date": "2026-08-07",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-08-07",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-07-21",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-05-12",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-04-29",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-02-19",
"gradingCompany": "Wells Fargo",
"previousGrade": "Equal Weight",
"newGrade": "Equal Weight",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-02-19",
"gradingCompany": "Benchmark",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2026-01-08",
"gradingCompany": "TD Cowen",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-12-19",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-11-28",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-11-18",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-11-04",
"gradingCompany": "Citizens",
"previousGrade": "Market Outperform",
"newGrade": "Market Outperform",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-10-27",
"gradingCompany": "JP Morgan",
"previousGrade": "Neutral",
"newGrade": "Neutral",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-10-20",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Overweight",
"newGrade": "Overweight",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-10-15",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "HALO",
"date": "2025-10-14",
"gradingCompany": "Leerink Partners",
"previousGrade": "Underperform",
"newGrade": "Market Perform",
"action": "upgrade"
},
{
"symbol": "HALO",
"date": "2025-10-02",
"gradingCompany": "HC Wainwright & Co.",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
}
]
}
Data:
[
{
"title": "Why Women-Run Companies Deserve a Place in Your Portfolio",
"url": "https://www.zacks.com/stock/news/2995408/why-women-run-companies-deserve-a-place-in-your-portfolio?cid=CS-STOCKNEWSAPI-FT-women_run_companies-2995408",
"source": "Zacks Investment Research",
"date": "2026-09-24 14:45:18",
"summary": "BMY, HALO, TGT, NEO and ROST stocks show how women-led companies are redefining growth with discipline, agility and results.",
"image": "https://images.financialmodelingprep.com/news/why-womenrun-companies-deserve-a-place-in-your-portfolio-20260924.jpg"
},
{
"title": "Halozyme Therapeutics (NASDAQ:HALO) Reaches New 12-Month High \u2013 Here\u2019s Why",
"url": "https://www.defenseworld.net/2026/09/24/halozyme-therapeutics-nasdaqhalo-reaches-new-12-month-high-heres-why.html",
"source": "Defense World",
"date": "2026-09-24 03:41:25",
"summary": "Halozyme Therapeutics, Inc. (NASDAQ: HALO - Get Free Report) reached a new 52-week high on Thursday. The stock traded as high as $116.85 and last traded at $112.44, with a volume of 2702748 shares. The stock had previously closed at $115.13. Wall Street Analyst Weigh In A number ",
"image": "https://images.financialmodelingprep.com/news/halozyme-therapeutics-nasdaqhalo-reaches-new-12month-high-heres-why-20260924.png"
},
{
"title": "Head to Head Review: Halozyme Therapeutics (NASDAQ:HALO) & Co-Diagnostics (NASDAQ:CODX)",
"url": "https://www.defenseworld.net/2026/09/24/head-to-head-review-halozyme-therapeutics-nasdaqhalo-co-diagnostics-nasdaqcodx.html",
"source": "Defense World",
"date": "2026-09-24 02:29:03",
"summary": "Halozyme Therapeutics (NASDAQ: HALO - Get Free Report) and Co-Diagnostics (NASDAQ: CODX - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, va",
"image": "https://images.financialmodelingprep.com/news/head-to-head-review-halozyme-therapeutics-nasdaqhalo-codiagnostics-nasdaqcodx-20260924.png"
},
{
"title": "If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now",
"url": "https://www.zacks.com/stock/news/2994202/if-you-invested-1000-in-halozyme-therapeutics-a-decade-ago-this-is-how-much-it-d-be-worth-now?cid=CS-ZC-FT-fundamental_analysis|investing_$1000-2994202",
"source": "Zacks Investment Research",
"date": "2026-09-23T12:30:14Z",
"summary": "A $1,000 investment in Halozyme Therapeutics made in September 2016 would be worth $9,284.68 as of September 23, 2026, representing an 828.47% gain. The biopharmaceutical company's growth is driven by royalties from its ENHANZE drug delivery technology licensed to major pharma pa",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default203.jpg"
},
{
"title": "Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength?",
"url": "https://www.zacks.com/stock/news/2994125/strength-seen-in-halozyme-therapeutics-halo-can-its-3-3-jump-turn-into-more-strength?cid=CS-ZC-FT-fundamental_analysis|daily_price_change_3%-2994125",
"source": "Zacks Investment Research",
"date": "2026-09-23T09:30:00Z",
"summary": "Halozyme Therapeutics shares rose 3.3% to $115.13 on strong volume, driven by investor optimism around its ENHANZE drug-delivery technology collaborations with major pharmaceutical companies. The company is expected to report quarterly earnings of $2.25 per share (+30.8% YoY) and",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default86.jpg"
},
{
"title": "Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns",
"url": "https://www.zacks.com/stock/news/2994505/add-these-4-garp-stocks-to-your-portfolio-to-receive-handsome-returns?cid=CS-STOCKNEWSAPI-FT-analyst_blog|rw-2994505",
"source": "Zacks Investment Research",
"date": "2026-09-23 11:35:39",
"summary": "The GARP strategy helps investors gain exposure to stocks that have solid prospects and are trading at a discount. FTNT, ABBNY, EAT and HALO are some such stocks.",
"image": "https://images.financialmodelingprep.com/news/add-these-4-garp-stocks-to-your-portfolio-to-20260923.jpg"
},
{
"title": "Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate",
"url": "https://www.zacks.com/stock/news/2993134/biotech-etfs-to-buy-as-cancer-drug-breakthroughs-accelerate?cid=CS-ZC-FT-etf_news_and_commentary-2993134",
"source": "Zacks Investment Research",
"date": "2026-09-21T16:03:00Z",
"summary": "Biotech companies are increasingly directing capital toward oncology therapeutics, with over $3.9 billion of venture capital flowing into cancer and immunology drug developers in H1 2026. The global oncology drugs market is projected to grow from $256.5 billion in 2025 to nearly ",
"image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg"
},
{
"title": "Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033",
"url": "https://www.gurufocus.com/news/9087350/halozyme-therapeutics-inc-announces-pricing-of-upsized-private-offering-of-13-billion-of-convertible-senior-notes-due-2033",
"source": "GuruFocus",
"date": "2026-09-18 00:00:00",
"summary": "Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033PR NewswireSAN DIEGO, Sept. 17, 20",
"image": "https://images.financialmodelingprep.com/news/halozyme-therapeutics-inc-announces-pricing-of-upsized-private-offering-20260918.png"
},
{
"title": "Bank of America Corp DE Makes New $214.50 Million Investment in Halozyme Therapeutics, Inc. $HALO",
"url": "https://www.defenseworld.net/2026/09/17/bank-of-america-corp-de-makes-new-214-50-million-investment-in-halozyme-therapeutics-inc-halo.html",
"source": "Defense World",
"date": "2026-09-17 03:28:21",
"summary": "Bank of America Corp DE purchased a new stake in shares of Halozyme Therapeutics, Inc. (NASDAQ: HALO) during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,740,561 shares of the biopharmaceutical company's ",
"image": "https://images.financialmodelingprep.com/news/bank-of-america-corp-de-makes-new-21450-million-20260917.png"
},
{
"title": "Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033",
"url": "https://www.prnewswire.com/news-releases/halozyme-therapeutics-inc-announces-proposed-offering-of-1-05-billion-of-convertible-senior-notes-due-2033--302881074.html",
"source": "PRNewsWire",
"date": "2026-09-16 16:30:00",
"summary": "SAN DIEGO, Sept. 16, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) (\"Halozyme\" or the \"Company\"), today announced that it intends to offer, subject to market conditions and other factors, $1.05 billion aggregate principal amount of convertible senior notes due 2",
"image": "https://images.financialmodelingprep.com/news/halozyme-therapeutics-inc-announces-proposed-offering-of-105-billion-20260916.jpg"
},
{
"title": "3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)",
"url": "https://www.zacks.com/stock/news/2990864/3-reasons-why-growth-investors-shouldn-t-overlook-halozyme-therapeutics-halo?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|yseop_template_11_growth-2990864",
"source": "Zacks Investment Research",
"date": "2026-09-16 13:46:07",
"summary": "Halozyme Therapeutics (HALO) could produce exceptional returns because of its solid growth attributes.",
"image": "https://images.financialmodelingprep.com/news/3-reasons-why-growth-investors-shouldnt-overlook-halozyme-therapeutics-20260916.jpg"
},
{
"title": "Halozyme Therapeutics, Inc. (HALO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript",
"url": "https://seekingalpha.com/article/4947147-halozyme-therapeutics-inc-halo-presents-at-h-c-wainwright-28th-annual-global-investment",
"source": "Seeking Alpha",
"date": "2026-09-16 13:21:40",
"summary": "Halozyme Therapeutics, Inc. (HALO) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/halozyme-therapeutics-inc-halo-presents-at-hc-wainwright-28th-20260916.jpg"
},
{
"title": "Halozyme Therapeutics, Inc. (HALO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"url": "https://seekingalpha.com/article/4946609-halozyme-therapeutics-inc-halo-presents-at-morgan-stanley-24th-annual-global-healthcare",
"source": "Seeking Alpha",
"date": "2026-09-15 13:01:38",
"summary": "Halozyme Therapeutics, Inc. (HALO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript",
"image": "https://images.financialmodelingprep.com/news/halozyme-therapeutics-inc-halo-presents-at-morgan-stanley-24th-20260915.jpg"
},
{
"title": "4 Value Stocks to Buy as Oil Surge Fuels Fed Rate Hike Fears",
"url": "https://www.zacks.com/stock/news/2989769/4-value-stocks-to-buy-as-oil-surge-fuels-fed-rate-hike-fears?cid=CS-STOCKNEWSAPI-FT-analyst_blog|rw-2989769",
"source": "Zacks Investment Research",
"date": "2026-09-15 10:41:40",
"summary": "Unlock your portfolio value by investing in high earnings yield stocks like Ternium, Halozyme, POSCO and Talos Energy.",
"image": "https://images.financialmodelingprep.com/news/4-value-stocks-to-buy-as-oil-surge-fuels-20260915.jpg"
},
{
"title": "4 Best PEG Value Stocks to Buy Now for Strong Growth & Return",
"url": "https://www.zacks.com/stock/news/2989436/4-best-peg-value-stocks-to-buy-now-for-strong-growth-return?cid=CS-STOCKNEWSAPI-FT-analyst_blog|rw-2989436",
"source": "Zacks Investment Research",
"date": "2026-09-14 16:21:08",
"summary": "These four PEG value stocks combine discounted valuations with strong growth prospects, offering investors potential opportunities amid market volatility.",
"image": "https://images.financialmodelingprep.com/news/4-best-peg-value-stocks-to-buy-now-for-20260914.jpg"
},
{
"title": "VIRGINIA RETIREMENT SYSTEMS ET Al Takes $1.02 Million Position in Halozyme Therapeutics, Inc. $HALO",
"url": "https://www.defenseworld.net/2026/09/14/virginia-retirement-systems-et-al-takes-1-02-million-position-in-halozyme-therapeutics-inc-halo.html",
"source": "Defense World",
"date": "2026-09-14 05:46:45",
"summary": "VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Halozyme Therapeutics, Inc. (NASDAQ: HALO) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 13,100 shares of the",
"image": "https://images.financialmodelingprep.com/news/virginia-retirement-systems-et-al-takes-102-million-position-20260914.png"
},
{
"title": "Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026",
"url": "https://www.globenewswire.com/news-release/2026/09/10/3359954/0/en/acumen-pharmaceuticals-to-hold-virtual-investor-day-on-september-16-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-10T20:00:00Z",
"summary": "Acumen Pharmaceuticals announced a virtual Investor Day scheduled for September 16, 2026, to discuss its clinical-stage pipeline. The company is advancing sabirnetug (ACU193), a monoclonal antibody targeting toxic amyloid beta oligomers for Alzheimer's disease treatment, with Pha",
"image": "https://ml.globenewswire.com/Resource/Download/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b"
},
{
"title": "Is Invesco S&P MidCap 400 Pure Growth ETF (RFG) a Strong ETF Right Now?",
"url": "https://www.zacks.com/stock/news/2986137/is-invesco-s-p-midcap-400-pure-growth-etf-rfg-a-strong-etf-right-now?cid=CS-ZC-FT-smart_beta_etf-2986137",
"source": "Zacks Investment Research",
"date": "2026-09-08T10:20:02Z",
"summary": "Invesco S&P MidCap 400 Pure Growth ETF (RFG) is reviewed as a smart beta ETF offering mid-cap growth exposure with a 0.35% expense ratio. The fund has delivered 16.08% year-to-date returns and 18.85% over the past year, with 102 holdings primarily concentrated in Industrials (27.",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default246.jpg"
},
{
"title": "Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences",
"url": "https://www.globenewswire.com/news-release/2026/09/02/3355470/0/en/acumen-pharmaceuticals-to-participate-in-upcoming-investor-conferences.html",
"source": "GlobeNewswire Inc.",
"date": "2026-09-02T20:00:00Z",
"summary": "Acumen Pharmaceuticals announced that management will participate in two upcoming investor conferences in September 2026: the Cantor Global Healthcare Conference on September 9 and Citi's 2026 Biopharma Back to School Conference on September 10. The company is advancing its lead ",
"image": "https://ml.globenewswire.com/Resource/Download/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b"
},
{
"title": "LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED\u00ae (testosterone enanthate) Injection",
"url": "https://www.globenewswire.com/news-release/2026/06/22/3315216/6480/en/LifeMD-Announces-Exclusive-Collaboration-to-Launch-Direct-to-Patient-Self-Pay-Program-for-XYOSTED-testosterone-enanthate-Injection.html",
"source": "GlobeNewswire Inc.",
"date": "2026-06-22T12:00:00Z",
"summary": "LifeMD announced an exclusive co-marketing collaboration with Halozyme's subsidiary Antares Pharma to launch a direct-to-patient self-pay program for XYOSTED, an FDA-approved testosterone auto-injector. The program will launch in July 2026 across 37 states, offering patients virt",
"image": "https://ml.globenewswire.com/Resource/Download/07c92c99-5645-4be8-a3b7-6d9392b7ccc4"
},
{
"title": "Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026",
"url": "https://www.globenewswire.com/news-release/2026/05/05/3288191/0/en/Acumen-Pharmaceuticals-to-Report-First-Quarter-Financial-Results-on-May-12-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-05-05T20:00:00Z",
"summary": "Acumen Pharmaceuticals announced it will report first quarter 2026 financial results on May 12, 2026, with a conference call and webcast at 8:00 a.m. ET. The clinical-stage biopharmaceutical company is advancing sabirnetug (ACU193), a monoclonal antibody targeting amyloid beta ol",
"image": "https://ml.globenewswire.com/Resource/Download/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b"
},
{
"title": "Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026",
"url": "https://www.globenewswire.com/news-release/2026/03/19/3259413/0/en/Acumen-Pharmaceuticals-to-Report-Fourth-Quarter-and-Year-End-2025-Financial-Results-on-March-26-2026.html",
"source": "GlobeNewswire Inc.",
"date": "2026-03-19T20:00:00Z",
"summary": "Acumen Pharmaceuticals announced it will report Q4 and year-end 2025 financial results on March 26, 2026, with a conference call at 8:00 a.m. ET. The clinical-stage biopharmaceutical company is advancing sabirnetug (ACU193), a monoclonal antibody targeting amyloid beta oligomers ",
"image": "https://ml.globenewswire.com/Resource/Download/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b"
},
{
"title": "Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum",
"url": "https://www.globenewswire.com/news-release/2026/03/10/3253291/0/en/Acumen-Pharmaceuticals-to-Participate-in-the-Stifel-2026-Virtual-CNS-Forum.html",
"source": "GlobeNewswire Inc.",
"date": "2026-03-10T20:00:00Z",
"summary": "Acumen Pharmaceuticals announced that management will participate in a fireside chat at the Stifel 2026 Virtual CNS Forum on March 18, 2026. The clinical-stage biopharmaceutical company is advancing sabirnetug (ACU193), a monoclonal antibody targeting toxic soluble amyloid beta o",
"image": "https://ml.globenewswire.com/Resource/Download/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b"
},
{
"title": "Halozyme Therapeutics Projects Sustained Growth Well Into 2040",
"url": "https://www.benzinga.com/markets/guidance/26/01/50203341/halozyme-therapeutics-projects-sustained-growth-well-into-2040?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2026-01-28T18:58:51Z",
"summary": "Halozyme Therapeutics raised its 2026 and multi-year financial guidance, projecting total revenue growth of 23-30% year-over-year to $1.71-$1.81 billion. Royalty revenue is expected to exceed $1 billion in 2026, growing 30-35%, one year ahead of previous projections. The company ",
"image": "https://cdn.benzinga.com/files/images/story/2026/01/28/Various-Pharmaceuticals-Pills-Capsules-T.jpeg?width=1200&height=800&fit=crop"
},
{
"title": "Immunotherapy Breakthroughs Turn Cold GI Tumors Hot as Market Tops $443B",
"url": "https://www.benzinga.com/pressreleases/25/12/n49430422/immunotherapy-breakthroughs-turn-cold-gi-tumors-hot-as-market-tops-443b?utm_source=benzinga_taxonomy&utm_medium=rss_feed_free&utm_content=taxonomy_rss&utm_campaign=channel",
"source": "Benzinga",
"date": "2025-12-16T18:17:00Z",
"summary": "Emerging immunotherapy technologies are transforming treatment for gastrointestinal cancers, with companies developing novel combination strategies to activate immune responses in historically resistant tumors. The global cancer immunotherapy market is projected to reach $443.17 ",
"image": "https://www.benzinga.com/next-assets/images/benzinga-schema-image-default.png"
}
]
Data:
[
{
"symbol": "HALO",
"date": "2026-11-02",
"epsActual": null,
"epsEstimated": 2.25,
"revenueActual": null,
"revenueEstimated": 482275300,
"lastUpdated": "2026-09-29"
},
{
"symbol": "HALO",
"date": "2026-08-06",
"epsActual": 2.28,
"epsEstimated": 1.79,
"revenueActual": 480999000,
"revenueEstimated": 402279700,
"lastUpdated": "2026-09-29"
},
{
"symbol": "HALO",
"date": "2026-05-11",
"epsActual": 1.6,
"epsEstimated": 1.55,
"revenueActual": 376708000,
"revenueEstimated": 358603300,
"lastUpdated": "2026-08-11"
},
{
"symbol": "HALO",
"date": "2026-02-17",
"epsActual": -0.24,
"epsEstimated": 2.15,
"revenueActual": 451767000,
"revenueEstimated": 435705600,
"lastUpdated": "2026-05-17"
},
{
"symbol": "HALO",
"date": "2025-11-03",
"epsActual": 1.72,
"epsEstimated": 1.63,
"revenueActual": 354264000,
"revenueEstimated": 446507800,
"lastUpdated": "2026-02-03"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "HALO",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "HALO",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260629",
"quantity_fails": 24256,
"price": 74.96
},
{
"file_period": "202607a",
"settlement_date": "20260709",
"quantity_fails": 750,
"price": 80.37
},
{
"file_period": "202607b",
"settlement_date": "20260731",
"quantity_fails": 1515,
"price": 83.3
},
{
"file_period": "202608a",
"settlement_date": "20260813",
"quantity_fails": 14,
"price": 101.79
},
{
"file_period": "202608b",
"settlement_date": "20260831",
"quantity_fails": 395,
"price": 105.35
}
],
"trend": "falling",
"trend_description": "FTD quantity declining \u2014 shorts covering or delivery improving"
}
}
Data:
{
"insider": [
{
"symbol": "HALO",
"filingDate": "2026-09-17",
"transactionDate": "2026-09-16",
"reportingCik": "0001543792",
"companyCik": "0001159036",
"transactionType": "S-Sale",
"securitiesOwned": 74735,
"reportingName": "Posard Matthew L.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3100,
"price": 106.132,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000123/0001159036-26-000123-index.htm"
},
{
"symbol": "HALO",
"filingDate": "2026-09-17",
"transactionDate": "2026-09-16",
"reportingCik": "0001543792",
"companyCik": "0001159036",
"transactionType": "S-Sale",
"securitiesOwned": 71735,
"reportingName": "Posard Matthew L.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 3000,
"price": 106.828,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000123/0001159036-26-000123-index.htm"
},
{
"symbol": "HALO",
"filingDate": "2026-09-17",
"transactionDate": "2026-09-16",
"reportingCik": "0001543792",
"companyCik": "0001159036",
"transactionType": "S-Sale",
"securitiesOwned": 62839,
"reportingName": "Posard Matthew L.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 8896,
"price": 108.04,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000123/0001159036-26-000123-index.htm"
},
{
"symbol": "HALO",
"filingDate": "2026-09-17",
"transactionDate": "2026-09-16",
"reportingCik": "0001543792",
"companyCik": "0001159036",
"transactionType": "S-Sale",
"securitiesOwned": 58839,
"reportingName": "Posard Matthew L.",
"typeOfOwner": "director",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 4000,
"price": 108.991,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000123/0001159036-26-000123-index.htm"
},
{
"symbol": "HALO",
"filingDate": "2026-09-11",
"transactionDate": "2026-09-11",
"reportingCik": "0001528185",
"companyCik": "0001159036",
"transactionType": "M-Exempt",
"securitiesOwned": 787780,
"reportingName": "Torley Helen",
"typeOfOwner": "director, officer: PRESIDENT AND CEO",
"acquisitionOrDisposition": "A",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 20000,
"price": 18.41,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000119/0001159036-26-000119-index.htm"
},
{
"symbol": "HALO",
"filingDate": "2026-09-11",
"transactionDate": "2026-09-09",
"reportingCik": "0001528185",
"companyCik": "0001159036",
"transactionType": "S-Sale",
"securitiesOwned": 774476,
"reportingName": "Torley Helen",
"typeOfOwner": "director, officer: PRESIDENT AND CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 13304,
"price": 107.222,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000119/0001159036-26-000119-index.htm"
},
{
"symbol": "HALO",
"filingDate": "2026-09-11",
"transactionDate": "2026-09-10",
"reportingCik": "0001528185",
"companyCik": "0001159036",
"transactionType": "S-Sale",
"securitiesOwned": 773192,
"reportingName": "Torley Helen",
"typeOfOwner": "director, officer: PRESIDENT AND CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 14588,
"price": 107.012,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000119/0001159036-26-000119-index.htm"
},
{
"symbol": "HALO",
"filingDate": "2026-09-11",
"transactionDate": "2026-09-11",
"reportingCik": "0001528185",
"companyCik": "0001159036",
"transactionType": "S-Sale",
"securitiesOwned": 772288,
"reportingName": "Torley Helen",
"typeOfOwner": "director, officer: PRESIDENT AND CEO",
"acquisitionOrDisposition": "D",
"directOrIndirect": "D",
"formType": "4",
"securitiesTransacted": 15492,
"price": 107.154,
"securityName": "Common Stock",
"url": "https://www.sec.gov/Archives/edgar/data/1159036/000115903626000119/0001159036-26-000119-index.htm"
}
],
"congress": [
{
"symbol": "HALO",
"senateID": "W000805",
"disclosureDate": "2017-12-08",
"transactionDate": "2017-11-06",
"firstName": "Mark R.",
"lastName": "Warner",
"office": "Mark R Warner",
"district": "VA",
"owner": "Self",
"assetDescription": "Halozyme Therapeutics, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$500,001 - $1,000,000",
"capitalGainsOver200USD": "False",
"comment": "Underlying asset of MRW Biotech Investors, LLC. Previously held in New River Management V.",
"link": "https://efdsearch.senate.gov/search/view/ptr/d94f6136-fd12-4105-910f-6f52c771faee/"
},
{
"symbol": "HALO",
"senateID": "C001123",
"disclosureDate": "2026-04-08",
"transactionDate": "2026-03-09",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Halozyme Therapeutics, Inc. - Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20034285.pdf"
},
{
"symbol": "HALO",
"senateID": "C001123",
"disclosureDate": "2025-04-07",
"transactionDate": "2025-03-24",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Halozyme Therapeutics, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20029026.pdf"
},
{
"symbol": "HALO",
"senateID": "G000583",
"disclosureDate": "2024-10-03",
"transactionDate": "2024-09-09",
"firstName": "Josh S.",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Halozyme Therapeutics, Inc. - Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2024/20025953.pdf"
},
{
"symbol": "HALO",
"senateID": "G000599",
"disclosureDate": "2023-08-13",
"transactionDate": "2023-07-12",
"firstName": "Daniel",
"lastName": "Goldman",
"office": "Daniel Goldman",
"district": "NY10",
"owner": "",
"assetDescription": "Halozyme Therapeutics, Inc.",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023404.pdf"
},
{
"symbol": "HALO",
"senateID": "G000583",
"disclosureDate": "2023-01-13",
"transactionDate": "2022-12-06",
"firstName": "Josh S.",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Halozyme Therapeutics, Inc.",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022219.pdf"
},
{
"symbol": "HALO",
"senateID": "C001123",
"disclosureDate": "2020-11-05",
"transactionDate": "2020-10-22",
"firstName": "Gilbert Ray",
"lastName": "Cisneros",
"office": "Gilbert Cisneros",
"district": "CA31",
"owner": "",
"assetDescription": "Halozyme Therapeutics, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017632.pdf"
},
{
"symbol": "HALO",
"senateID": "G000583",
"disclosureDate": "2020-11-05",
"transactionDate": "2020-10-19",
"firstName": "Josh S.",
"lastName": "Gottheimer",
"office": "Josh Gottheimer",
"district": "NJ05",
"owner": "Joint",
"assetDescription": "Halozyme Therapeutics, Inc.",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2020/20017634.pdf"
}
],
"dark_pool": [
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:00:18.864000Z",
"size": 223379.0,
"price": 112.89,
"premium": 25217255.31,
"volume": 223379.0,
"trade_code": " "
},
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:00:01.368000Z",
"size": 117500.0,
"price": 112.89,
"premium": 13264575.0,
"volume": 117500.0,
"trade_code": "6"
},
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:00:18.862000Z",
"size": 26621.0,
"price": 112.89,
"premium": 3005244.69,
"volume": 26621.0,
"trade_code": " "
},
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:01:17.540000Z",
"size": 26100.0,
"price": 113.63,
"premium": 2965743.0,
"volume": 26100.0,
"trade_code": " "
},
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:00:01.368000Z",
"size": 12500.0,
"price": 112.89,
"premium": 1411125.0,
"volume": 12500.0,
"trade_code": "6"
},
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:00:01.368000Z",
"size": 12500.0,
"price": 112.89,
"premium": 1411125.0,
"volume": 12500.0,
"trade_code": "6"
},
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:00:01.368000Z",
"size": 12500.0,
"price": 112.89,
"premium": 1411125.0,
"volume": 12500.0,
"trade_code": "6"
},
{
"ticker": "HALO",
"executed_at": "2026-09-28T20:00:01.368000Z",
"size": 4125.0,
"price": 112.89,
"premium": 465671.25,
"volume": 4125.0,
"trade_code": "6"
}
],
"ats": {
"symbol": "HALO",
"date": "20260928",
"ats_volume": 0,
"total_volume": 830219,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20260928",
"ats_ratio": 0.0
},
{
"date": "20260925",
"ats_ratio": 0.0
},
{
"date": "20260924",
"ats_ratio": 0.0
},
{
"date": "20260923",
"ats_ratio": 0.0
},
{
"date": "20260922",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "HALO",
"days": [
{
"date": "2026-09-28",
"close": 112.89,
"vwap": 113.03,
"volume": 2236750,
"vwap_discount_pct": 0.13
},
{
"date": "2026-09-25",
"close": 113.9,
"vwap": 114.14,
"volume": 1958390,
"vwap_discount_pct": 0.21
},
{
"date": "2026-09-24",
"close": 115.22,
"vwap": 114.84,
"volume": 3172136,
"vwap_discount_pct": -0.33
},
{
"date": "2026-09-23",
"close": 112.44,
"vwap": 113.46,
"volume": 2702793,
"vwap_discount_pct": 0.91
},
{
"date": "2026-09-22",
"close": 115.13,
"vwap": 114.19,
"volume": 4151542,
"vwap_discount_pct": -0.82
}
],
"avg_vwap_discount_pct": 0.02,
"signal": "Neutral"
},
"options_flow": [
{
"volume": 68,
"option_type": "call",
"open_interest": 70,
"nbbo_ask": "4.30",
"implied_volatility": "0.3979492221015185",
"size": 28,
"delta": "0.3882747199871846",
"executed_at": "2026-09-28T13:42:30.665000Z",
"option_chain_id": "HALO261120C00120000",
"sector": "Healthcare",
"price": "4.30",
"strike": "120",
"underlying_symbol": "HALO",
"expiry": "2026-11-20",
"nbbo_bid": "3.70",
"underlying_price": "112.94",
"premium": "12040.00"
},
{
"volume": 3,
"option_type": "call",
"open_interest": 104,
"nbbo_ask": "39.50",
"implied_volatility": "0.69474130870212",
"size": 3,
"delta": "0.923200782248312",
"executed_at": "2026-09-28T15:43:19.121000Z",
"option_chain_id": "HALO261218C00075000",
"sector": "Healthcare",
"price": "39.50",
"strike": "75",
"underlying_symbol": "HALO",
"expiry": "2026-12-18",
"nbbo_bid": "37.40",
"underlying_price": "112.34",
"premium": "11850.00"
},
{
"volume": 3,
"option_type": "call",
"open_interest": 369,
"nbbo_ask": "35.00",
"implied_volatility": "0.659984899763919",
"size": 3,
"delta": "0.899321631938991",
"executed_at": "2026-09-28T15:43:19.121000Z",
"option_chain_id": "HALO261218C00080000",
"sector": "Healthcare",
"price": "35.00",
"strike": "80",
"underlying_symbol": "HALO",
"expiry": "2026-12-18",
"nbbo_bid": "32.90",
"underlying_price": "112.34",
"premium": "10500.00"
}
],
"net_premium": {
"ticker": "HALO",
"net_call_premium": "23691.00",
"net_put_premium": "1063.00",
"call_premium": "126067.00",
"put_premium": "9279.00",
"bullish_premium": "75307.00",
"bearish_premium": "52679.00",
"put_call_ratio": "0.328042328042328042328042328",
"iv_rank": "43.489",
"implied_move_perc": "0.07",
"gex_ratio": "0.24192512984119881755",
"gex_net_change": "404.4844",
"gex_call": "14077.4422",
"gex_put": "-3520.5527",
"gex_net": 10556.8895,
"gex_call_delta": "709681.8585",
"gex_put_delta": "-52063.3438",
"gex_date": "2026-09-29"
},
"hot_chains": [
{
"open_interest": 70,
"volume": 86,
"last_price": "4.13",
"option_symbol": "HALO261120C00120000",
"ask_volume": 45,
"bid_volume": 41,
"nbbo_bid": "2.35",
"nbbo_ask": "4.60",
"avg_price": "4.2101162790697674418604651164"
},
{
"open_interest": 62,
"volume": 35,
"last_price": "1.64",
"option_symbol": "HALO261218P00095000",
"ask_volume": 21,
"bid_volume": 8,
"nbbo_bid": "0.70",
"nbbo_ask": "2.40",
"avg_price": "1.6382857142857142857142857143"
},
{
"open_interest": 201,
"volume": 23,
"last_price": "2.25",
"option_symbol": "HALO261016C00115000",
"ask_volume": 6,
"bid_volume": 17,
"nbbo_bid": "2.00",
"nbbo_ask": "2.60",
"avg_price": "2.4995652173913043478260869565"
},
{
"open_interest": 374,
"volume": 14,
"last_price": "4.88",
"option_symbol": "HALO261218C00120000",
"ask_volume": 2,
"bid_volume": 12,
"nbbo_bid": "3.30",
"nbbo_ask": "6.80",
"avg_price": "5.0535714285714285714285714284"
},
{
"open_interest": 127,
"volume": 12,
"last_price": "0.70",
"option_symbol": "HALO261016P00105000",
"ask_volume": 2,
"bid_volume": 10,
"nbbo_bid": "0.50",
"nbbo_ask": "2.60",
"avg_price": "0.7133333333333333333333333333"
},
{
"open_interest": 120,
"volume": 11,
"last_price": "1.12",
"option_symbol": "HALO261016C00120000",
"ask_volume": 3,
"bid_volume": 7,
"nbbo_bid": "0.15",
"nbbo_ask": "1.50",
"avg_price": "1.1109090909090909090909090909"
},
{
"open_interest": 427,
"volume": 10,
"last_price": "9.66",
"option_symbol": "HALO261218C00110000",
"ask_volume": 10,
"bid_volume": 0,
"nbbo_bid": "7.80",
"nbbo_ask": "11.20",
"avg_price": "9.6600"
},
{
"open_interest": 153,
"volume": 7,
"last_price": "5.30",
"option_symbol": "HALO261016C00110000",
"ask_volume": 1,
"bid_volume": 4,
"nbbo_bid": "4.40",
"nbbo_ask": "6.70",
"avg_price": "5.2885714285714285714285714285"
}
],
"gamma_profile": {
"ticker": "HALO",
"spot": 113.12,
"date": "2026-09-29",
"flip_point": 77.39,
"net_gex": 10556.89,
"call_walls": [
{
"strike": 110.0,
"gex": 2951.48
},
{
"strike": 115.0,
"gex": 2217.1
},
{
"strike": 120.0,
"gex": 2053.64
}
],
"put_walls": [
{
"strike": 110.0,
"gex": -1167.9
},
{
"strike": 100.0,
"gex": -658.09
},
{
"strike": 105.0,
"gex": -630.82
}
],
"by_strike": [
{
"strike": 55.0,
"call_gex": 0.66,
"put_gex": -5.44,
"net_gex": -4.78
},
{
"strike": 60.0,
"call_gex": 2.93,
"put_gex": -35.72,
"net_gex": -32.79
},
{
"strike": 65.0,
"call_gex": 25.0,
"put_gex": -29.97,
"net_gex": -4.97
},
{
"strike": 70.0,
"call_gex": 50.52,
"put_gex": -18.41,
"net_gex": 32.11
},
{
"strike": 75.0,
"call_gex": 37.45,
"put_gex": -93.92,
"net_gex": -56.47
},
{
"strike": 80.0,
"call_gex": 177.81,
"put_gex": -39.55,
"net_gex": 138.26
},
{
"strike": 85.0,
"call_gex": 414.82,
"put_gex": -48.26,
"net_gex": 366.56
},
{
"strike": 90.0,
"call_gex": 644.82,
"put_gex": -107.67,
"net_gex": 537.16
},
{
"strike": 95.0,
"call_gex": 298.66,
"put_gex": -107.51,
"net_gex": 191.15
},
{
"strike": 100.0,
"call_gex": 535.73,
"put_gex": -658.09,
"net_gex": -122.37
},
{
"strike": 105.0,
"call_gex": 620.36,
"put_gex": -630.82,
"net_gex": -10.46
},
{
"strike": 110.0,
"call_gex": 2951.48,
"put_gex": -1167.9,
"net_gex": 1783.58
},
{
"strike": 115.0,
"call_gex": 2217.1,
"put_gex": -421.7,
"net_gex": 1795.4
},
{
"strike": 120.0,
"call_gex": 2053.64,
"put_gex": -145.81,
"net_gex": 1907.83
},
{
"strike": 125.0,
"call_gex": 965.48,
"put_gex": -5.95,
"net_gex": 959.53
},
{
"strike": 130.0,
"call_gex": 185.15,
"put_gex": -0.19,
"net_gex": 184.97
},
{
"strike": 135.0,
"call_gex": 811.63,
"put_gex": -0.01,
"net_gex": 811.62
},
{
"strike": 140.0,
"call_gex": 1824.5,
"put_gex": 0.0,
"net_gex": 1824.5
},
{
"strike": 145.0,
"call_gex": 14.29,
"put_gex": 0.0,
"net_gex": 14.29
},
{
"strike": 150.0,
"call_gex": 31.32,
"put_gex": -1.7,
"net_gex": 29.63
},
{
"strike": 155.0,
"call_gex": 191.28,
"put_gex": 0.0,
"net_gex": 191.28
},
{
"strike": 160.0,
"call_gex": 19.35,
"put_gex": 0.0,
"net_gex": 19.35
},
{
"strike": 165.0,
"call_gex": 0.66,
"put_gex": 0.0,
"net_gex": 0.66
},
{
"strike": 170.0,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
}
]
},
"oi_changes": {
"net_call_oi_change": -1,
"net_put_oi_change": 0,
"top": [
{
"strike": null,
"oi_change": -1,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
},
{
"strike": null,
"oi_change": 0,
"type": "call"
}
]
},
"opds": {
"opds": 0.5,
"D": 2.5,
"P": 13.8,
"O": 18.7,
"C": 21.6,
"signal": "NEUTRAL",
"direction": "bullish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": -1.2,
"T": 46.2,
"RS": 30.2,
"V": -16.7,
"F": 100.0,
"OI": -100.0,
"S": null,
"IV": 58.3,
"B": null,
"Liquidity": 0.0,
"OpeningConfidence": 0.0,
"FlowAgreement": 66.7,
"StrikeBreadth": 50.0
},
"drivers": [
"+ aggressive flow +100",
"- open-interest change -100",
"+ IV behaviour +58",
"+ trend +46",
"+ relative strength +30"
]
}
}
Data:
{
"vix": 14.81,
"sp500": 7704.13,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.31,
"hy_spread": 2.73,
"treasury": {
"date": "2026-09-25",
"month1": 4.04,
"month2": 4.2,
"month3": 4.24,
"month6": 4.33,
"year1": 4.5,
"year2": 4.81,
"year3": 4.94,
"year5": 4.98,
"year7": 5.06,
"year10": 5.17,
"year20": 5.54,
"year30": 5.49
},
"events": [
{
"title": "Core PCE Price Index m/m",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.2%",
"actual": null,
"minutes_until": 1410
},
{
"title": "Final GDP q/q",
"currency": "USD",
"date": "2026-09-30",
"time_utc": "12:30",
"impact": "High",
"forecast": "1.5%",
"previous": "1.5%",
"actual": null,
"minutes_until": 1410
},
{
"title": "Average Hourly Earnings m/m",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "0.3%",
"previous": "0.3%",
"actual": null,
"minutes_until": 4290
},
{
"title": "Non-Farm Employment Change",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "90K",
"previous": "162K",
"actual": null,
"minutes_until": 4290
},
{
"title": "Unemployment Rate",
"currency": "USD",
"date": "2026-10-02",
"time_utc": "12:30",
"impact": "High",
"forecast": "4.1%",
"previous": "4.1%",
"actual": null,
"minutes_until": 4290
}
]
}
Data:
{
"days": 102,
"patterns": [
{
"name": "VWAP Touch",
"count": 102,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 102,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 100,
"pct": 98
},
{
"name": "Woodie Pivot Touch",
"count": 95,
"pct": 93
},
{
"name": "PDH/PDL Touch",
"count": 89,
"pct": 87
},
{
"name": "Open Retracement",
"count": 80,
"pct": 78
},
{
"name": "Gap Fill",
"count": 74,
"pct": 73
},
{
"name": "High Vol Open",
"count": 24,
"pct": 24
},
{
"name": "Darvas Box",
"count": 22,
"pct": 22
},
{
"name": "Power Hour",
"count": 14,
"pct": 14
}
]
}